<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-08079R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0005156</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry/Chemical Biology of the Cell</subject><subject>Biochemistry/Drug Discovery</subject><subject>Chemical Biology/Protein Chemistry and Proteomics</subject><subject>Infectious Diseases/Neglected Tropical Diseases</subject></subj-group></article-categories><title-group><article-title>Hemoglobin Cleavage Site-Specificity of the <italic>Plasmodium falciparum</italic> Cysteine Proteases Falcipain-2 and Falcipain-3</article-title><alt-title alt-title-type="running-head">Falcipain Hemoglobin Cleavage</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Subramanian</surname><given-names>Shoba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn1"><sup>&#x000a4;a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hardt</surname><given-names>Markus</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn2"><sup>&#x000a4;b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Choe</surname><given-names>Youngchool</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="author-notes" rid="fn3"><sup>&#x000a4;c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Niles</surname><given-names>Richard K.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Johansen</surname><given-names>Eric B.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Legac</surname><given-names>Jennifer</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gut</surname><given-names>Jiri</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kerr</surname><given-names>Iain D.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Craik</surname><given-names>Charles S.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rosenthal</surname><given-names>Philip J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Medicine, Division of Infectious Diseases, University of California San Francisco, San Francisco, California, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, California, United States of America</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, United States of America</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Rodrigues</surname><given-names>Mauricio Martins</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Federal University of S&#x000e3;o Paulo, Brazil</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>prosenthal@medsfgh.ucsf.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: SS MH CC PJR. Performed the experiments: SS MH YC RKN EBJ JL JG. Analyzed the data: SS MH YC RKN EBJ IDk CC. Contributed reagents/materials/analysis tools: SS MH CC. Wrote the paper: SS MH PJR.</p></fn><fn id="fn1" fn-type="current-aff"><label>&#x000a4;a</label><p>Current address: Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America</p></fn><fn id="fn2" fn-type="current-aff"><label>&#x000a4;b</label><p>Current address: Boston Biomedical Research Institute, Watertown, Massachusetts, United States of America</p></fn><fn id="fn3" fn-type="current-aff"><label>&#x000a4;c</label><p>Current address: Catalyst Biosciences, South San Francisco, California, United States of America</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>9</day><month>4</month><year>2009</year></pub-date><volume>4</volume><issue>4</issue><elocation-id>e5156</elocation-id><history><date date-type="received"><day>8</day><month>1</month><year>2009</year></date><date date-type="accepted"><day>10</day><month>3</month><year>2009</year></date></history><copyright-statement>Subramanian et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><p>The <italic>Plasmodium falciparum</italic> cysteine proteases falcipain-2 and falcipain-3 degrade host hemoglobin to provide free amino acids for parasite protein synthesis. Hemoglobin hydrolysis has been described as an ordered process initiated by aspartic proteases, but cysteine protease inhibitors completely block the process, suggesting that cysteine proteases can also initiate hemoglobin hydrolysis. To characterize the specific roles of falcipains, we used three approaches. First, using random P<sub>1</sub> &#x02013; P<sub>4</sub> amino acid substrate libraries, falcipain-2 and falcipain-3 demonstrated strong preference for cleavage sites with Leu at the P<sub>2</sub> position. Second, with overlapping peptides spanning &#x003b1; and &#x003b2; globin and proteolysis-dependent <sup>18</sup>O labeling, hydrolysis was seen at many cleavage sites. Third, with intact hemoglobin, numerous cleavage products were identified. Our results suggest that hemoglobin hydrolysis by malaria parasites is not a highly ordered process, but rather proceeds with rapid cleavage by falcipains at multiple sites. However, falcipain-2 and falcipain-3 show strong specificity for P<sub>2</sub> Leu in small peptide substrates, in agreement with the specificity in optimized small molecule inhibitors that was identified previously. These results are consistent with a principal role of falcipain-2 and falcipain-3 in the hydrolysis of hemoglobin by <italic>P. falciparum</italic> and with the possibility of developing small molecule inhibitors with optimized specificity as antimalarial agents.</p></abstract><counts><page-count count="10"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Malaria, especially that caused by <italic>Plasmodium falciparum</italic>, is responsible for hundreds of millions of episodes of disease, and probably at least one million deaths each year <xref ref-type="bibr" rid="pone.0005156-Snow1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Breman1">&#x0005b;2&#x0005d;</xref>. Among impediments to effective control of this disease is increasing resistance to most available drugs <xref ref-type="bibr" rid="pone.0005156-Wongsrichanalai1">&#x0005b;3&#x0005d;</xref>. New artemisinin-based combination therapies offer excellent efficacy, but resistance to most artemisinin partner drugs has already been seen <xref ref-type="bibr" rid="pone.0005156-Nosten1">&#x0005b;4&#x0005d;</xref>, and resistance to artemisinins may be emerging <xref ref-type="bibr" rid="pone.0005156-Alker1">&#x0005b;5&#x0005d;</xref>. The pipeline for development of other classes of effective antimalarials, especially compounds that act against novel biochemical targets, is limited. To facilitate development of such compounds, it is important to characterize the biochemical features and biological roles of new drug targets.</p><p>Falcipain-2 and falcipain-3 are papain-family cysteine proteases of <italic>P. falciparum</italic> that are currently the subjects of in-depth drug discovery efforts <xref ref-type="bibr" rid="pone.0005156-Rosenthal1">&#x0005b;6&#x0005d;</xref>. These proteases are expressed sequentially across the life cycle of erythrocytic parasites, with expression of falcipain-2 beginning in early trophozoites followed by expression of falcipain-3 in late trophozoites and schizonts <xref ref-type="bibr" rid="pone.0005156-Dahl1">&#x0005b;7&#x0005d;</xref>. The proteases are hemoglobinases that reside in the food vacuole of intraerythrocytic parasites, where they degrade hemoglobin, in concert with other proteases <xref ref-type="bibr" rid="pone.0005156-Rosenthal2">&#x0005b;8&#x0005d;</xref>, to provide the parasite with amino acids for growth and development <xref ref-type="bibr" rid="pone.0005156-Liu1">&#x0005b;9&#x0005d;</xref>. Treatment of erythrocytic parasites with cysteine protease inhibitors or disruption of the falcipain-2 gene results in accumulation of undegraded hemoglobin in the food vacuole, confirming a role for this enzyme in hemoglobin hydrolysis <xref ref-type="bibr" rid="pone.0005156-Rosenthal1">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Sijwali1">&#x0005b;10&#x0005d;</xref>. Disruption of the falcipain-3 gene could not be achieved, but the gene was readily replaced with a tagged functional copy, indicating that falcipain-3 is essential for survival of intraerythrocytic parasites <xref ref-type="bibr" rid="pone.0005156-Sijwali2">&#x0005b;11&#x0005d;</xref>. These results support studies of falcipain inhibitors as new antimalarial agents.</p><p>The hydrolysis of hemoglobin by malaria parasites is a massive proteolytic enterprise, which appears to be responsible for the degradation of most erythrocytic hemoglobin over the course of a 48 hour developmental cycle <xref ref-type="bibr" rid="pone.0005156-Rosenthal2">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Francis1">&#x0005b;12&#x0005d;</xref>. It has been described as an ordered pathway, with initial cleavage by aspartic proteases followed by action of other proteases, eventually leading to free amino acids <xref ref-type="bibr" rid="pone.0005156-Francis1">&#x0005b;12&#x0005d;</xref>. However, falcipain inhibitors completely block hemoglobin hydrolysis by erythrocytic parasites <xref ref-type="bibr" rid="pone.0005156-GamboadeDominguez1">&#x0005b;13&#x0005d;</xref>, and falcipain-2 and falcipain-3 hydrolyze native hemoglobin under the biochemical conditions of the food vacuole <xref ref-type="bibr" rid="pone.0005156-Shenai1">&#x0005b;14&#x0005d;</xref>, suggesting that falcipains also initiate hemoglobin hydrolysis in <italic>P. falciparum</italic>. To better characterize the roles of falcipain-2 and falcipain-3, we evaluated activities of these proteases against a library of small peptide substrates, a series of larger peptides spanning the sequences of &#x003b1; and &#x003b2; globin, and intact human hemoglobin. Falcipain-2 and falcipain-3 demonstrated a marked preference for cleavage of small peptide substrates with P<sub>2</sub> Leu, but the enzymes showed less specificity against larger peptides and intact hemoglobin, with hydrolysis at multiple sites. These results suggest that hemoglobin hydrolysis by <italic>P. falciparum</italic> is not a highly ordered process, but rather that falcipain-2 and falcipain-3 rapidly cleave hemoglobin at multiple sites to facilitate rapid hydrolysis of this substrate.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Synthesis of Recombinant Falcipains</title><p>Expression, solubilization and refolding of falcipain-2 and falcipain-3 were performed as described elsewhere, with slight modifications <xref ref-type="bibr" rid="pone.0005156-Shenai2">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Sijwali3">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Sijwali4">&#x0005b;17&#x0005d;</xref>. In brief, urea solubilized inclusion bodies from bacteria over-expressing the mature domains of either falcipain-2 or falcipain-3 fused to a 6&#x000d7;HIS tag were purified by ultra-filtration and bound to Nickel-Nitrilotriacetic acid (Ni-NTA) columns. After several washes with buffer containing 8 M urea and 10&#x02013;60 mM imidazole, bound protein was eluted sequentially with 500 mM and 1 M imidazole in the presence of urea. Refolding of falcipain-2 was achieved by diluting the eluates 100-fold in 100 mM Tris-HCl, 30&#x00025; glycerol, 250 mM arginine, 1 mM EDTA, 1 mM reduced-glutathione (GSH), 1 mM oxidized-glutathione (GSSG), pH 9.2 and incubating at 4&#x000b0;C overnight. Refolding of falcipain-3 was achieved by diluting the eluates 100-fold in 100 mM Tris-HCl, 15&#x00025; sucrose, 250 mM arginine, 1 mM EDTA, 1 mM GSH, 1 mM GSSG, pH 9.2 and incubating at 4&#x000b0;C overnight. The refolded proteins were concentrated 50-fold, run over a Q-Sepharose column, and eluted with a gradient of NaCl starting at 500 mM. Eluates were examined by SDS-PAGE and for activity against the synthetic substrate, Z-Leu-Arg-AMC (benzyloxycarbonyl-Leu-Arg-7-amino-4-methyl-coumarin). Fractions with highest enzyme activity were pooled and concentrated using a 10 KDa cut-off ultra-filtration column (Amicon). Enzymes were stored in 50&#x00025; glycerol at &#x02212;80&#x000b0;C.</p></sec><sec id="s2b"><title>P<sub>1</sub>- P<sub>4</sub> Specificity Determination Using Tetrapeptide Scanning Libraries</title><p>To determine the P<sub>1</sub>- P<sub>4</sub> specificity of falcipain-2 and falcipain-3, complete diverse positional scanning substrate libraries were used <xref ref-type="bibr" rid="pone.0005156-Choe1">&#x0005b;18&#x0005d;</xref>. The libraries were composed of peptide-conjugated ACC (7-amino-4-carbamoylmethylcoumarin) fluorophore substrates and contained 160,000 different P<sub>1</sub>- P<sub>4</sub> peptide sequences. In the P<sub>1</sub>-, P<sub>2</sub>-, P<sub>3</sub>-, and P<sub>4</sub>- libraries, the P<sub>1</sub>-<sub>4</sub> positions were spatially addressed with 20 amino acids (cysteine was replaced with norleucine); whereas the remaining three positions were randomized with equimolar mixtures of 20 amino acids (cysteine was replaced with norleucine). The cleavage of the substrates by a protease released free ACC, resulting in a shift of the excitation and emission maxima from 325 and 400 nm to 380 and 460 nm, respectively.</p><p>Falcipain-2 (50 nM) and falcipain-3 (300 nM) were assayed in triplicate at 25&#x000b0;C in 100 mM sodium acetate, 100 mM NaCl, 1 mM DTT, 1 mM EDTA, 0.01&#x00025; Brij-35, 1&#x00025; v/v DMSO, pH 5.5. Aliquots of 25 nmol (in 1 &#x000b5;l) from each of 20 sub-libraries of the P<sub>1</sub>-, P<sub>2</sub>-, P<sub>3</sub>-, and P<sub>4</sub>- libraries were added to the wells of a 96-well Microfluor-1 U-bottom plate (Dynex Technologies). The final concentration of each compound was 31.25 nM in 100 &#x000b5;l final reaction volume. The assays were initiated by addition of pre-activated enzyme and monitored fluorometrically for 30 min with a SpectraMax Gemini fluorescence spectrometer (Molecular Devices) with excitation at 380 nm, emission at 460 nm, and cutoff at 435 nm.</p></sec><sec id="s2c"><title>Hydrolysis of globin peptides in the presence of H<sub>2</sub><sup>18</sup>O</title><p>Synthetic peptides of 12 amino acid length scanning the entire sequences of &#x003b1; and &#x003b2; globin, with 4 amino acid overlaps between peptides, were custom-ordered from Sigma-Genosys. Each peptide (250 mM) was incubated in duplicate with 65 nM falcipain-2 or falcipain-3 in 25 mM sodium acetate, pH 5.5, 2 mM DTT, and 50&#x00025; H<sub>2</sub><sup>18</sup>O at 37&#x000b0;C. Reactions were started by adding enzyme after spotting the 0 minute time point. Aliquots were spotted after 0, 5, 10, 15, 20, 40, 60, 75, 90, 120, and 180 minutes, and overnight directly onto stainless steel MALDI-target plates (Applied Biosystems) and mixed with an equal volume of matrix (10 mg/ml sinapinic acid in 50&#x00025; acetonitrile, 0.1&#x00025; trifluoroacetic acid) which stopped the proteolytic reactions. MALDI-TOF MS/MS analysis was performed on a 4800 Proteomics Analyzer mass spectrometer (Applied Biosystems) in positive ion mode equipped with TOF/TOF optics and a 200 Hz NdYag laser. For collision-induced dissociation, the collision cell was floated at 1 kV, the resolution of the precursor ion selection was set to 150 FWHM, and air was used as the collision gas at 5&#x000d7;10<sup>&#x02212;7</sup> Torr.</p></sec><sec id="s2d"><title>Analysis of peptide hydrolysis data</title><p>In the presence of H<sub>2</sub><sup>18</sup>O, protease-peptide interactions can result in the incorporation of up to two <sup>18</sup>O-atoms in carboxylate peptide products <xref ref-type="bibr" rid="pone.0005156-Robinson1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Miyagi1">&#x0005b;20&#x0005d;</xref>. The second incorporation, which depends on the ability of the enzyme to rebind the cleaved peptide product and catalyze the carbonyl oxygen exchange reaction, was rarely observed. Therefore, in the presence of 50&#x00025; H<sub>2</sub><sup>18</sup>O, peptides that were proteolytically generated displayed an <sup>18</sup>O-isotope signature of 1&#x02236;1 (unlabeled: single labeled) at their newly-formed C-termini.</p><p>The extent of <sup>18</sup>O incorporation for each peptide was determined by linear regression analysis of the raw spectra using least squares fitting with a model consisting of a linear combination of four components, the theoretical average in isotope clusters positioned at m/z, (m&#x0002b;2)/z and (m&#x0002b;4)/z, and a constant term. Linear regression computed four multipliers, the amplitude of the unlabeled, singly-labeled, and doubly-labeled peaks, and the baseline. It was thereby possible to measure the unlabeled, singly labeled, and doubly labeled contributions for each peptide identified in the mass spectrum.</p><p>We used the following criteria to positively identify new cleavage products: a) a new C-terminus had to be formed to allow <sup>18</sup>O-incorporation; b) the single <sup>18</sup>O-incorporation had to account for 50&#x00025; of the entire isotopic envelope (&#x000b1;10&#x00025; experimental error); c) peptide needed to be observed in replicate analyses and in consecutive time points (except for the overnight time point); and d) labeled peptide should not be detected at the zero time point, with the following exceptions: e) peptides that started off with &#x0003e;60&#x00025; unlabeled fraction, with subsequent decrease in unlabeled peptide were included; f) peptides with initial single label, followed by double label were included; g) peptides with single label in a minority of time points slightly &#x0003e;60&#x00025; were included; h) if the single label significantly increased with time, peptides with slight labeling at 0 min were included; and i) As expected, proteolytic products that were formed while the C-termini stayed intact did not incorporate <sup>18</sup>O. Hence, these newly generated peptides with intact C-termini: 1) should display less than 20&#x00025; labeling (accounting for experimental error); 2) these peptides should be seen in at least two time points and in replicate analyses (unless it is observed only in the overnight time point); and 3) these unlabeled peptides should not be seen at not at the zero time point.</p></sec><sec id="s2e"><title>Hydrolysis of Human Hemoglobin</title><p>For analysis of hydrolysis of intact hemoglobin, reaction conditions and enzyme concentration were as described for experiments with 12-mer peptides, except that the substrate was 2.5 &#x000b5;M human hemoglobin (Sigma) and were incubated for 180 minutes or overnight. At the end of the incubation, peptides were separated by ultra-filtration (12,000&#x000d7;g for 40 min; Sartorius Vivaspin columns, nominal molecular weight limit 3,000 or 5,000 Daltons). Ultra-filtrates containing the cleavage products were analyzed by LC MS/MS on a QStar XL mass spectrometer (Applied Biosystems/Sciex) equipped with a nano 2DLC system (Eksigent) and a Nanospray II source (Applied Biosystems/Sciex). External calibration was performed in MS/MS mode using fragment ions of Glu-fibrinopeptide as references. An LC Packings PepMap C18 trap column (300 &#x000b5;m i.d., 5 mm length, 300 &#x000c5; pore size, 5 &#x000b5;m particle size) and a column (75 &#x000b5;m i.d., 15 cm length) self-packed with Jupiter Proteo C12 end-capped material (90 &#x000c5; pore size, 4 &#x000b5;m particle size) were used for desalting and reversed phase peptide separation, respectively. A 20 minute linear gradient from 2&#x00025; B to 50&#x00025; B was run at a 250 nL/min flow rate, utilizing solvents A: (2&#x00025; acetonitrile/0.1&#x00025; formic acid) and B (80&#x00025; acetonitrile/0.08&#x00025; formic acid). Precursor ion selection employed an automated routine that consisted of a one survey MS scan (1 s, m/z 400&#x02013;1700) and two MS/MS scans (1 s, m/z 60&#x02013;1500); nitrogen served as a collision gas and collision energy was automatically adjusted depending on the size and charge state of the precursor ion. Mass spectrometry data were analyzed using a laboratory information system that utilized Mascot Distiller software (Matrix Science) for spectral processing and peak detection. Peptides were identified by using the Mascot algorithm (Matrix Science; version 2.1) to search against human proteins in the SwissProt database via nonspecific digestion (<italic>i.e.</italic> &#x0201c;no enzyme&#x0201d; search). Identities of peptides were confirmed by manual interpretation of the MS/MS data.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Expression of falcipain-2 and falcipain-3</title><p>Falcipain-2 and falcipain-3 were expressed in bacteria, purified, and refolded to active proteases. These proteases have previously been shown to readily hydrolyze hemoglobin <xref ref-type="bibr" rid="pone.0005156-Shenai2">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Sijwali4">&#x0005b;17&#x0005d;</xref>, and also to cleave peptide substrates after Leu-Arg-, Val-Leu-Arg-, and Val-Leu-Lys- <xref ref-type="bibr" rid="pone.0005156-Sijwali4">&#x0005b;17&#x0005d;</xref>. These substrates were tested based on the known specificities of other papain family cysteine proteases <xref ref-type="bibr" rid="pone.0005156-Barrett1">&#x0005b;21&#x0005d;</xref>. However, more detailed characterization of the substrate specificity of these proteases has not been reported. To better characterize falcipain activities and determine whether a clear pathway of hemoglobin degradation by falcipains is present, activities were studied by three assays, evaluating action against a tetrapeptide library, 12-mer peptides representing the sequences of &#x003b1; and &#x003b2; globin, and intact hemoglobin. All assays were performed under conditions matching, to the best of our knowledge, those of the <italic>P. falciparum</italic> food vacuole, the site of hemoglobin hydrolysis by the falcipains, notably at pH 5.5.</p></sec><sec id="s3b"><title>Hydrolysis of a positional scanning tetrapeptide library</title><p>To study the amino acid preferences of falcipain-2 and falcipain-3 at the P<sub>1</sub> to P<sub>4</sub> positions, we studied hydrolysis of positional scanning tetrapeptide libraries (<xref ref-type="fig" rid="pone-0005156-g001">Fig. 1</xref>). In each library, each tetrapeptide had a fixed amino acid at one position (P<sub>1</sub>, P<sub>2</sub>, P<sub>3</sub>, or P<sub>4</sub>) and randomized amino acids at the other positions <xref ref-type="bibr" rid="pone.0005156-Choe1">&#x0005b;18&#x0005d;</xref>. P<sub>1</sub> preferences for the two enzymes were similar. Both falcipain-2 and falcipain-3 showed a P<sub>1</sub> preference for Arg, with activity also high against substrates with P<sub>1</sub> Lys, Gln, Thr, and Met. Considering the P<sub>2</sub> position, both falcipain-2 and falcipain-3 had a strong preference for Leu and a slight preference for Val. Amino acid preferences were less pronounced at the P<sub>3</sub> and P<sub>4</sub> positions, although specificities for the two enzymes were similar. At P<sub>3</sub>, positively charged amino acids, hydrophobic amino acids, and Pro were preferred. P<sub>4</sub> His and Asn were preferred by both enzymes, with particularly low activity against peptides with hydrophobic amino acids at P<sub>4</sub>.</p><fig id="pone-0005156-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005156.g001</object-id><label>Figure 1</label><caption><title>Cleavage preferences of falcipain-2 and falcipain-3 against a tetrapeptide library.</title><p>P<sub>1</sub> P<sub>2</sub>, P<sub>3</sub> and P<sub>4</sub> complete diverse libraries were used to determine specificities. Activities are displayed as percentage of the maximum for each position. Amino acids are represented by the single-letter code (n is for norleucine). Error bars represent standard deviations of results from three experiments.</p></caption><graphic xlink:href="pone.0005156.g001"/></fig></sec><sec id="s3c"><title>Hydrolysis of globin peptides</title><p>We next evaluated cleavage of 12-mer peptides spanning the sequences of &#x003b1; and &#x003b2; globin, with 4 amino acid overlaps such that each potential cleavage site was considered with at least 3 P or P&#x02032; amino acids present. To best distinguish falcipain cleavage products from minor fragments contaminating synthetic peptides, the proteases and peptide substrates were incubated with 50&#x00025; H<sub>2</sub><sup>18</sup>O. With proteolytic cleavage, the C-terminal ends of the newly generated peptides, but not false products, bore <sup>18</sup>O either by enzyme catalysis or isotope exchange <xref ref-type="bibr" rid="pone.0005156-Robinson1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Miyagi1">&#x0005b;20&#x0005d;</xref>. Peptides were incubated with falcipain-2 or falcipain-3 for varied intervals, and reaction products were assessed by MALDI-TOF MS/MS analysis. We used stringent criteria to distinguish newly generated peptides from false positive and ambiguous products, based on ratios of labeled to unlabeled peptides and frequencies of appearance at several time points. Multiple cleavage sites were identified for both falcipains (<xref ref-type="fig" rid="pone-0005156-g002">Fig. 2a&#x02013;d</xref>, top arrows). Considering the sequences most preferred in our positional scanning library analysis, cleavages by falcipain-2 were seen at 25 of 36 positions with P<sub>2</sub> Leu and by falcipain-3 at 22 of 36 such positions. Analysis of the step-wise hydrolysis of peptides over time yielded a complex picture for both &#x003b1; and &#x003b2; globin and either falcipain-2 or falcipain-3 (<xref ref-type="fig" rid="pone-0005156-g003">Fig. 3</xref>). Identification of the most common amino acids at cleavage sites was, of course, influenced by the prevalence of different residues in hemoglobin. At the P<sub>2</sub> position, Leu was most common, but cleavages of peptides with P<sub>2</sub> Val and other amino acids were also well represented (<xref ref-type="fig" rid="pone-0005156-g004">Fig. 4</xref>). A more thorough analysis of cleavage for each amino acid at each P<sub>1&#x02013;4</sub> position is in supplementary material (<xref ref-type="supplementary-material" rid="pone.0005156.s002">Table S1</xref>; <xref ref-type="supplementary-material" rid="pone.0005156.s001">Figure S1</xref>). These experiments also showed that the most preferred P<sub>1</sub>&#x02032; amino acids were Ala and Leu. However, this preference was modest, with cleavages demonstrated at sites with multiple different prime-side amino acids. At the P<sub>2</sub>&#x02032; position Ala was slightly preferred. There was no particular amino acid preference at the P<sub>3</sub>&#x02032; or P<sub>4</sub>&#x02032; position.</p><fig id="pone-0005156-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005156.g002</object-id><label>Figure 2</label><caption><title>Hemoglobin cleavage sites for falcipain-2 and falcipain-3.</title><p>A&#x02013;D. Globin peptides and intact human hemoglobin. Cleavage sites for the two proteases based on analysis as described in <xref ref-type="sec" rid="s2">Methods</xref> of hydrolysis of 12-mer peptides (top arrows, data from all time points) and intact hemoglobin (lower arrows, data from both 180 min and overnight time points) are shown for &#x003b1; and &#x003b2; globin. E. Intact human hemoglobin. The schematic shows &#x003b1; globin subunits in white and &#x003b2; globin subunits in yellow. P<sub>1</sub> residues at cleavage sites within helices are in red and within loops are in blue.</p></caption><graphic xlink:href="pone.0005156.g002"/></fig><fig id="pone-0005156-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005156.g003</object-id><label>Figure 3</label><caption><title>Time course for cleavage of globin peptides.</title><p>Schematic representation of cleavage fragments over the indicated time points based on analysis of cleavage of 12-mer peptides spanning the sequences of &#x003b1; and &#x003b2; globin.</p></caption><graphic xlink:href="pone.0005156.g003"/></fig><fig id="pone-0005156-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005156.g004</object-id><label>Figure 4</label><caption><title>Cleavage site preferences for falcipain-2 and falcipain-3.</title><p>Preferences for amino acids (single letter code) at P<sub>1</sub>-P<sub>4</sub> and P<sub>1</sub>&#x02032;-P<sub>4</sub>&#x02032; are shown schematically. At each position, the height of each amino acid corresponds to its frequency at cleavage sites based on analysis of &#x003b1; and &#x003b2; globin. WebLogo (<ext-link ext-link-type="uri" xlink:href="http://weblogo.berkeley.edu">weblogo.berkeley.edu</ext-link>), a free software for plotting consensus sequences, was used to plot P<sub>4-</sub> P<sub>4</sub>&#x02032; preferences.</p></caption><graphic xlink:href="pone.0005156.g004"/></fig></sec><sec id="s3d"><title>Hydrolysis of intact human hemoglobin</title><p>For our third analysis, we assessed hydrolysis of full-length hemoglobin by falcipain-2 and falcipain-3. A simple step-wise pathway for hemoglobin degradation was not seen. Rather, we identified over a hundred peptides of molecular weight 9 kDa or less after 5 minute incubations of human hemoglobin with falcipain-2 or falcipain-3 (data not shown). For simplicity, we therefore concentrated on identification of hemoglobin cleavage fragments after an extended incubation with falcipain-2 or falcipain-3. Reactions were performed after incubation of hemoglobin with 50&#x00025; H<sub>2</sub><sup>18</sup>O, and the identities of hemoglobin cleavage fragments were characterized by LC-MS/MS. Data were filtered based on <sup>18</sup>O incorporation, as described above for analysis of peptide hydrolysis. We then mapped cleavage sites on the sequences of &#x003b1; and &#x003b2; globin (<xref ref-type="fig" rid="pone-0005156-g002">Fig. 2a&#x02013;d</xref>, bottom arrows). Cleavage sites were identified in both the loops (blue color) and helices (red color) of human globin, with no particular preference for buried or exposed cleavage sites on the hemoglobin tertiary structure (<xref ref-type="fig" rid="pone-0005156-g002">Fig. 2e</xref>). Of note, the data obtained for falcipain-2 were nearly identical to those for falcipain-3 for hydrolysis of hemoglobin and were very similar to those for hydrolysis of globin peptides by both proteases.</p></sec></sec><sec id="s4"><title>Discussion</title><p>Falcipain-2 and falcipain-3 are critical hemoglobinases of <italic>P. falciparum</italic>. These enzymes have been extensively studied, with characterization of kinetic properties <xref ref-type="bibr" rid="pone.0005156-Shenai2">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Sijwali4">&#x0005b;17&#x0005d;</xref>, confirmation of key functions with inhibitor <xref ref-type="bibr" rid="pone.0005156-Rosenthal3">&#x0005b;22&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Rosenthal4">&#x0005b;23&#x0005d;</xref> and gene disruption studies <xref ref-type="bibr" rid="pone.0005156-Sijwali1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Sijwali2">&#x0005b;11&#x0005d;</xref>, and identification of unique motifs that are required for protein folding <xref ref-type="bibr" rid="pone.0005156-Sijwali5">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Pandey1">&#x0005b;25&#x0005d;</xref>, interaction with hemoglobin <xref ref-type="bibr" rid="pone.0005156-Pandey2">&#x0005b;26&#x0005d;</xref>, enzyme structure <xref ref-type="bibr" rid="pone.0005156-Hogg1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Kerr1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Wang1">&#x0005b;29&#x0005d;</xref>, and targeting to the parasite food vacuole <xref ref-type="bibr" rid="pone.0005156-Subramanian1">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Dasaradhi1">&#x0005b;31&#x0005d;</xref>. However, characterization of a specific pathway for hemoglobin hydrolysis by falcipain-2 and falcipain-3 has been difficult. We now present a detailed analysis of hydrolysis of short peptide substrates, 12-mer peptides encompassing &#x003b1; and &#x003b2; globin, and intact human hemoglobin by falcipain-2 and falcipain-3. We show that the proteases have distinct specificity for short peptide substrates with Leu at the P<sub>2</sub> position, but that against larger substrates specificity is less marked. Indeed, the proteases rapidly cleaved globin peptides and intact hemoglobin at multiple different sequences. These results suggest that falcipain-2 and falcipain-3 do not cleave host hemoglobin via an ordered process, but rather that the proteases efficiently cleave the substrate by rapid hydrolysis at many different sites on the protein.</p><p>We evaluated hydrolysis of small peptide combinatorial libraries by falcipains, a standard technique. Other proteases that have been evaluated in this manner include caspases <xref ref-type="bibr" rid="pone.0005156-Thornberry1">&#x0005b;32&#x0005d;</xref>, the serine protease granzyme b <xref ref-type="bibr" rid="pone.0005156-Thornberry1">&#x0005b;32&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Ruggles1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Harris1">&#x0005b;34&#x0005d;</xref>, a coronavirus cysteine protease <xref ref-type="bibr" rid="pone.0005156-Goetz1">&#x0005b;35&#x0005d;</xref>, a tick asparaginyl endopeptidase <xref ref-type="bibr" rid="pone.0005156-Sojka1">&#x0005b;36&#x0005d;</xref>, and human kalikreins <xref ref-type="bibr" rid="pone.0005156-Debela1">&#x0005b;37&#x0005d;</xref>. Although this methodology is most useful for highly selective enzymes, valuable information can also be extracted from substrate profiles with enzymes that are quite promiscuous, as in the case of the falcipains and other papain family cysteine proteases <xref ref-type="bibr" rid="pone.0005156-Barrett1">&#x0005b;21&#x0005d;</xref>. Of note, we observed marked selectivity in P<sub>2</sub> preference for falcipains using small peptide substrates. Hydrophobic amino acids at P<sub>2</sub> were strongly preferered by falcipain-2 and falcipain-3, as seen with many other papain-family proteases <xref ref-type="bibr" rid="pone.0005156-Barrett1">&#x0005b;21&#x0005d;</xref>. However, the specific preference for a single amino acid, Leu, at P<sub>2</sub>, was more striking than the case for any of the 8 other papain-family proteases recently studied in the same manner <xref ref-type="bibr" rid="pone.0005156-Choe1">&#x0005b;18&#x0005d;</xref>. Of the 8 other proteases, the next most specific enzyme was papain, with about 5-fold greater activity for peptides with Val at P<sub>2</sub> than any other peptides. Other papain-family proteases not included in the prior survey appear to show a stronger preference for P<sub>2</sub> Leu, notably the human proteases cathepsin K and cathepsin S <xref ref-type="bibr" rid="pone.0005156-Barrett1">&#x0005b;21&#x0005d;</xref>. As discussed in more detail below, we found that the striking preference for P<sub>2</sub> Leu in small substrates did not predict specificity only for cleavage sites with P<sub>2</sub> Leu in larger peptide or protein substrates. Nonetheless, this specificity has been seen also in small molecule inhibitors of falcipain-2 and falcipain-3; inhibitors with either Phe or Leu at P<sub>2</sub> were effective, but typically activity improved &#x0223c;10-fold for fluoromethyl ketones, vinyl sulfones, and aldehydes with P<sub>2</sub> Leu <xref ref-type="bibr" rid="pone.0005156-Rosenthal4">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Rosenthal5">&#x0005b;38&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Lee1">&#x0005b;39&#x0005d;</xref>. Thus, although of limited utility in discriminating activity against native protein substrates, the elaboration of enzyme specificity using tetrapeptide scanning libraries provided accurate prediction of optimal small molecule inhibitors. Appreciation of the fine specificity of inhibition of falcipains is contributing to drug discovery efforts directed against these proteases <xref ref-type="bibr" rid="pone.0005156-Rosenthal1">&#x0005b;6&#x0005d;</xref>.</p><p>Our experimental conditions for globin peptides and native hemoglobin were slightly modified from a previous study <xref ref-type="bibr" rid="pone.0005156-Shenai1">&#x0005b;14&#x0005d;</xref>, so that they were suited for <sup>18</sup>O incorporation and subsequent mass spectrometry. These conditions were designed to match those in the intact food vacuole, including modest reducing conditions (1 mM DTT) and pH of 5.5. Prior studies have estimated the pH of the food vacuole at 4.5&#x02013;5.8 <xref ref-type="bibr" rid="pone.0005156-Kuhn1">&#x0005b;40&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Bennett1">&#x0005b;41&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Krogstad1">&#x0005b;42&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Yayon1">&#x0005b;43&#x0005d;</xref> and shown the pH optima of falcipain-2 and falcipain-3 to be &#x0223c;4.5&#x02013;6.0 <xref ref-type="bibr" rid="pone.0005156-Shenai2">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Sijwali4">&#x0005b;17&#x0005d;</xref>. The enzyme&#x02236;substrate ratio was slightly higher than that used previously <xref ref-type="bibr" rid="pone.0005156-Shenai1">&#x0005b;14&#x0005d;</xref>; these conditions gave us optimum results with substrate degradation and <sup>18</sup>O incorporation, which is also an enzyme-dependent process.</p><p>Ordered pathways for the hydrolysis of hemoglobin have been demonstrated in studies with isolated aspartic proteases from two parasites that hydrolyze this substrate, schistosome worms that degrade hemoglobin extracellularly <xref ref-type="bibr" rid="pone.0005156-Brindley1">&#x0005b;44&#x0005d;</xref> and malaria parasites that degrade hemoglobin in an intracellular acidic organelle <xref ref-type="bibr" rid="pone.0005156-Francis1">&#x0005b;12&#x0005d;</xref>. However, prior attempts to map out pathways of hemoglobin hydrolysis for cysteine proteases of schistosomes or malaria parasites have been unsuccessful due to an inability to identify the ordered generation of cleavage fragments (Shenai BR, Sajid M, and Rosenthal PJ, unpublished observations). A key goal of the present study was to more rigorously test the hypothesis that falcipain-2 and falcipain-3 indeed hydrolyze hemoglobin through an ordered pathway of cleavage events and, in any event, to identify globin peptide and hemoglobin cleavage fragments after incubation with falcipains. Despite rigorous filtering to identify only bona fide cleavage fragments, we found that falcipain-2 and falcipain-3 cleaved hemoglobin simultaneously (within our limits of analysis) at many sites. Thus, the enzymes appear to degrade hemoglobin not via an ordered hydrolytic pathway, but through rapid hydrolysis of multiple sites. This result is consistent with known features of other papain-family cysteine proteases, which also have quite broad specificity against protein substrates <xref ref-type="bibr" rid="pone.0005156-Barrett1">&#x0005b;21&#x0005d;</xref>. Indeed, the prototype enzyme papain is used in a number of industrial applications that take advantage of its broad substrate specificity. Lysosomal cysteine proteases similarly demonstrate broad specificity, and appear to be responsible for extensive proteolytic activity in this organelle <xref ref-type="bibr" rid="pone.0005156-Barrett1">&#x0005b;21&#x0005d;</xref>. In malaria parasites, where the food vacuole appears to serve as the homolog of the lysosome, and where hemoglobin appears to be the primary proteolytic substrate <xref ref-type="bibr" rid="pone.0005156-Francis1">&#x0005b;12&#x0005d;</xref>, it seems likely that falcipain-2 and falcipain-3 are responsible for the bulk of cleavages that reduce hemoglobin from a complex tetramer to single amino acids. Additional proteases, notably plasmepsin I&#x02013;IV <xref ref-type="bibr" rid="pone.0005156-Francis1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Banerjee1">&#x0005b;45&#x0005d;</xref>, dipeptidyl aminopeptidase I <xref ref-type="bibr" rid="pone.0005156-Klemba1">&#x0005b;46&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Dalal1">&#x0005b;47&#x0005d;</xref> and falcilysin <xref ref-type="bibr" rid="pone.0005156-Eggleson1">&#x0005b;48&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Murata1">&#x0005b;49&#x0005d;</xref>, also appear to contribute to the efficient hydrolysis of hemoglobin in the food vacuole, and the presence of multiple proteases of multiple classes suggests a degree of redundancy in this process <xref ref-type="bibr" rid="pone.0005156-Liu1">&#x0005b;9&#x0005d;</xref>. Despite the presence of multiple proteases in the food vacuole, it is noteworthy that treatment of cultured parasites with specific inhibitors of cysteine proteases fully blocked the hydrolysis of hemoglobin, highlighting the key role for the falcipains in this process <xref ref-type="bibr" rid="pone.0005156-Rosenthal3">&#x0005b;22&#x0005d;</xref>. Knockout of plasmepsins I&#x02013;IV, the 4 known food vacuole plasmepsins, was not lethal to <italic>P. falciparum</italic> (although parasites with knockout of all four food vacuole plasmepsins demonstrated abnormal development) <xref ref-type="bibr" rid="pone.0005156-Bonilla1">&#x0005b;50&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Bonilla2">&#x0005b;51&#x0005d;</xref>. In contrast, knockout of either falcipain-3 <xref ref-type="bibr" rid="pone.0005156-Sijwali2">&#x0005b;11&#x0005d;</xref> or dipeptidyl aminopeptidase I <xref ref-type="bibr" rid="pone.0005156-Klemba1">&#x0005b;46&#x0005d;</xref> appears to be lethal, arguing for essential functions for these enzymes, although it is not known if the essential functions are hydrolysis of hemoglobin. Of note, it has recently also been shown that the activation of food vacuole plasmepsins is primarily mediated by falcipains, offering further evidence of a primary role for falcipains in mediating the hydrolysis of hemoglobin by erythrocytic <italic>P. falciparum</italic> parasites <xref ref-type="bibr" rid="pone.0005156-Drew1">&#x0005b;52&#x0005d;</xref>.</p><p>Results showing potent hydrolysis of hemoglobin by both falcipain-2 and falcipain-3 <xref ref-type="bibr" rid="pone.0005156-Shenai1">&#x0005b;14 and this report&#x0005d;</xref> and the localization of these falcipains in the food vacuole <xref ref-type="bibr" rid="pone.0005156-Dahl1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Subramanian1">&#x0005b;30&#x0005d;</xref> argue that a key function of these proteases is hemoglobin hydrolysis. However, it remains possible that they also perform other key functions, including the processing of plasmepsins (as discussed above) and possibly other food vacuole proteases <xref ref-type="bibr" rid="pone.0005156-Drew1">&#x0005b;52&#x0005d;</xref> and the hydrolysis of erythrocyte cytoskeletal proteins to facilitate erythrocyte rupture <xref ref-type="bibr" rid="pone.0005156-Hanspal1">&#x0005b;53&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Dhawan1">&#x0005b;54&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Dasaradhi2">&#x0005b;55&#x0005d;</xref>. As falcipain-2 and falcipain-3 are not biochemically identical and as they are expressed sequentially during the parasite life cycle, they may have non-overlapping biological roles, explaining in part the redundancy of papain-family proteases in <italic>P. falciparum</italic>.</p><p>Of interest, falcipain-2 and falcipain-3 contain a short C-terminal insertion that is unique among studied papain-family proteases and mediates interaction between the proteases and hemoglobin independent of the enzyme active site <xref ref-type="bibr" rid="pone.0005156-Wang1">&#x0005b;29&#x0005d;</xref>. Removal of the insertion from falcipain-2 rendered a protease that remained active against peptide substrates, but could not hydrolyze hemoglobin <xref ref-type="bibr" rid="pone.0005156-Pandey2">&#x0005b;26&#x0005d;</xref>. This feature of the falcipains likely facilitates particularly efficient hydrolysis of hemoglobin and may contribute to the ability of the proteases to cleave hemoglobin at multiple sites. However, it is difficult to predict interaction between the protease and substrate based on known structures <xref ref-type="bibr" rid="pone.0005156-Kerr1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Wang1">&#x0005b;29&#x0005d;</xref>, as once initial cleavages of hemoglobin take place, the structure of hemoglobin will be altered, and multiple peptide bonds will presumably be accessible to cleavage by the falcipains.</p><p>A prior study identified hemoglobin cleavage fragments after incubation of this protein with crude <italic>P. falciparum</italic> food vacuole extracts <xref ref-type="bibr" rid="pone.0005156-Kolakovich1">&#x0005b;56&#x0005d;</xref>. This analysis identified a series of hemoglobin cleavage fragments, with cleavage sites at mean intervals of 8.4 amino acids. Comparison of identified cleavage sites from the prior analysis of food vacuole extracts with our analysis of cleavage by recombinant falcipains identified many shared cleavage sites, but also cleavages identified only after incubation with food vacuole extract or only after incubation with recombinant falcipains. Specifically, only 15 of 37 cleavages identified in the prior study after incubation with food vacuole extracts were seen after incubation with falcipain-2 or falcipain-3. Therefore, some hemoglobin cleavages appeared to be generated uniquely by proteases other than the falcipains. However, considering both our globin peptides and intact hemoglobin results, we observed over 100 different cleavage sites within hemoglobin, with 90 of these not seen after incubation with food vacuole extract. Some falcipain activity may have been missed in studies of vacuole extracts due to chosen assay conditions, the presence of enzyme inhibitors in extracts, or loss of enzymes during sample preparation. In any event, our new results suggest that, although a diverse set of proteases is likely required for optimal hydrolysis of hemoglobin, the sequential expression of falcipain-2 in early trophozoites and then falcipain-3 in late trophozoites and schizonts <xref ref-type="bibr" rid="pone.0005156-Dahl1">&#x0005b;7&#x0005d;</xref> provides potent hemoglobinolytic activity for erythrocytic <italic>P. falciparum</italic> parasites.</p><p>Our study has important limitations. First, the precise analysis of cleavage of globin peptides or hemoglobin by falcipains proved to be technically very challenging. Analysis of products after incubations of globin peptides with the proteases identified many products, suggesting the presence of contaminating fragments in commercial peptides. We therefore used <sup>18</sup>O labeling and assessments for reproducibility over time to identify genuine cleavage fragments. However, this approach necessarily involved the establishment of arbitrary filtering criteria, and may have inappropriately excluded some cleavage sites and/or included false cleavage sites. Second, analysis of cleavage of intact hemoglobin was cost- and labor-intensive, limiting our ability to evaluate a broad range of hydrolytic time points. Thus, our ability to identify any single hemoglobin cleavage site for falcipain-2 or falcipain-3 from our studies is somewhat limited, although cleavages seen consistently with both falcipains at multiple time points and with both peptide and intact hemoglobin substrates are very likely to represent true biological cleavage sites. Third, our study used ultrafiltration to isolate peptide cleavage fragments generated from intact hemoglobin. This procedure might lead to selective loss of certain peptides. To investigate that possibility, we previously analyzed tryptic digests of proteins prior to and after ultrafiltration, and we did not observe significant differences between the samples (Hardt, M., unpublished observation). Nonetheless, we cannot exclude the possibility that certain peptides might have been lost due to this separation technology, but, based on our overall sequence coverage of hemoglobin, this potential loss appeared to be minimal. In any event, our overall result is clear: falcipain-2 and falcipain-3 are capable of rapid hydrolysis of hemoglobin at multiple cleavage sites.</p><p>It is of interest that two common polymorphisms leading to alterations in the sequence of hemoglobin, HbS and HbC, offer protection against severe malaria <xref ref-type="bibr" rid="pone.0005156-Modiano1">&#x0005b;57&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Fairhurst1">&#x0005b;58&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-May1">&#x0005b;59&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Williams1">&#x0005b;60&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005156-Aidoo1">&#x0005b;61&#x0005d;</xref>, and many other polymorphisms in hemoglobin may offer protection against malaria. It is possible that this protection is mediated, in part, by altered susceptibility of mutant hemoglobins to hydrolysis by parasite proteases, including falcipains. This will be an interesting area for future study.</p><p>In summary, we have characterized the proteolytic specificity of two key cysteine protease hemoglobinases of the malaria parasite <italic>P. falciparum</italic>. Both falcipain-2 and falcipain-3, which are expressed sequentially, contribute importantly to the necessary hydrolysis of hemoglobin by intraerythrocytic parasites. Indeed, our results show that the falcipains rapidly hydrolyze hemoglobin at multiple sites, allowing efficient degradation of this substrate, and suggesting that the falcipains are the key proteases responsible for the massive hydrolysis of hemoglobin that occurs over the course of the intraerythrocytic life cycle of <italic>P. falciparum</italic>.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0005156.s001"><label>Figure S1</label><caption><p>Graphical representation of amino acid preferences at P1&#x02013;P4. P1&#x02013;P4 amino acid preferences were plotted as a percentage of total cleavages, alongside percentage occurrence of each amino acid in the primary sequences of &#x003b1; and &#x003b2; globin.</p><p>(0.51 MB TIF)</p></caption><media xlink:href="pone.0005156.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005156.s002"><label>Table S1</label><caption><p>This table shows (in two separate worksheets) sequences of the precursor peptide (for 12mer &#x003b1; and &#x003b2; globin peptides) and peptide products obtained as a result of falcipain mediated proteolysis.</p><p>(0.05 MB XLS)</p></caption><media xlink:href="pone.0005156.s002.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list><title>References</title><ref id="pone.0005156-Snow1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Snow</surname><given-names>RW</given-names></name><name><surname>Guerra</surname><given-names>CA</given-names></name><name><surname>Noor</surname><given-names>AM</given-names></name><name><surname>Myint</surname><given-names>HY</given-names></name><name><surname>Hay</surname><given-names>SI</given-names></name></person-group><year>2005</year><article-title>The global distribution of clinical episodes of Plasmodium falciparum malaria.</article-title><source>Nature</source><volume>434</volume><fpage>214</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">15759000</pub-id></citation></ref><ref id="pone.0005156-Breman1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breman</surname><given-names>JG</given-names></name></person-group><year>2001</year><article-title>The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden.</article-title><source>Am J Trop Med Hyg</source><volume>64</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">11425172</pub-id></citation></ref><ref id="pone.0005156-Wongsrichanalai1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wongsrichanalai</surname><given-names>C</given-names></name><name><surname>Pickard</surname><given-names>AL</given-names></name><name><surname>Wernsdorfer</surname><given-names>WH</given-names></name><name><surname>Meshnick</surname><given-names>SR</given-names></name></person-group><year>2002</year><article-title>Epidemiology of drug-resistant malaria.</article-title><source>Lancet Infect Dis</source><volume>2</volume><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">11937421</pub-id></citation></ref><ref id="pone.0005156-Nosten1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nosten</surname><given-names>F</given-names></name><name><surname>White</surname><given-names>NJ</given-names></name></person-group><year>2007</year><article-title>Artemisinin-based combination treatment of falciparum malaria.</article-title><source>Am J Trop Med Hyg</source><volume>77</volume><fpage>181</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">18165491</pub-id></citation></ref><ref id="pone.0005156-Alker1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alker</surname><given-names>AP</given-names></name><name><surname>Lim</surname><given-names>P</given-names></name><name><surname>Sem</surname><given-names>R</given-names></name><name><surname>Shah</surname><given-names>NK</given-names></name><name><surname>Yi</surname><given-names>P</given-names></name><etal/></person-group><year>2007</year><article-title>Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.</article-title><source>Am J Trop Med Hyg</source><volume>76</volume><fpage>641</fpage><lpage>647</lpage><pub-id pub-id-type="pmid">17426163</pub-id></citation></ref><ref id="pone.0005156-Rosenthal1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2004</year><article-title>Cysteine proteases of malaria parasites.</article-title><source>Int J Parasitol</source><volume>34</volume><fpage>1489</fpage><lpage>1499</lpage><pub-id pub-id-type="pmid">15582526</pub-id></citation></ref><ref id="pone.0005156-Dahl1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname><given-names>EL</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2005</year><article-title>Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum.</article-title><source>Mol Biochem Parasitol</source><volume>139</volume><fpage>205</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">15664655</pub-id></citation></ref><ref id="pone.0005156-Rosenthal2"><label>8</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2005</year><article-title>Proteases and hemoglobin degradation.</article-title><person-group person-group-type="editor"><name><surname>Sherman</surname><given-names>IW</given-names></name></person-group><source>Molecular approaches to malaria</source><publisher-loc>Washington, D.C.</publisher-loc><publisher-name>ASM press</publisher-name><fpage>311</fpage><lpage>326</lpage></citation></ref><ref id="pone.0005156-Liu1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Istvan</surname><given-names>ES</given-names></name><name><surname>Gluzman</surname><given-names>IY</given-names></name><name><surname>Gross</surname><given-names>J</given-names></name><name><surname>Goldberg</surname><given-names>DE</given-names></name></person-group><year>2006</year><article-title>Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems.</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>8840</fpage><lpage>8845</lpage><pub-id pub-id-type="pmid">16731623</pub-id></citation></ref><ref id="pone.0005156-Sijwali1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sijwali</surname><given-names>PS</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2004</year><article-title>Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.</article-title><source>Proc Natl Acad Sci U S A</source><volume>101</volume><fpage>4384</fpage><lpage>4389</lpage><pub-id pub-id-type="pmid">15070727</pub-id></citation></ref><ref id="pone.0005156-Sijwali2"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sijwali</surname><given-names>PS</given-names></name><name><surname>Koo</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2006</year><article-title>Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum.</article-title><source>Mol Biochem Parasitol</source><volume>150</volume><fpage>96</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">16890302</pub-id></citation></ref><ref id="pone.0005156-Francis1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>SE</given-names></name><name><surname>Sullivan</surname><given-names>DJ</given-names><suffix>Jr</suffix></name><name><surname>Goldberg</surname><given-names>DE</given-names></name></person-group><year>1997</year><article-title>Hemoglobin metabolism in the malaria parasite Plasmodium falciparum.</article-title><source>Annu Rev Microbiol</source><volume>51</volume><fpage>97</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">9343345</pub-id></citation></ref><ref id="pone.0005156-GamboadeDominguez1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gamboa de Dominguez</surname><given-names>ND</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>1996</year><article-title>Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites.</article-title><source>Blood</source><volume>87</volume><fpage>4448</fpage><lpage>4454</lpage><pub-id pub-id-type="pmid">8639807</pub-id></citation></ref><ref id="pone.0005156-Shenai1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shenai</surname><given-names>BR</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2002</year><article-title>Reducing requirements for hemoglobin hydrolysis by Plasmodium falciparum cysteine proteases.</article-title><source>Mol Biochem Parasitol</source><volume>122</volume><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">12076775</pub-id></citation></ref><ref id="pone.0005156-Shenai2"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shenai</surname><given-names>BR</given-names></name><name><surname>Sijwali</surname><given-names>PS</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2000</year><article-title>Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum.</article-title><source>J Biol Chem</source><volume>275</volume><fpage>29000</fpage><lpage>29010</lpage><pub-id pub-id-type="pmid">10887194</pub-id></citation></ref><ref id="pone.0005156-Sijwali3"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sijwali</surname><given-names>PS</given-names></name><name><surname>Brinen</surname><given-names>LS</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2001</year><article-title>Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2.</article-title><source>Protein Expr Purif</source><volume>22</volume><fpage>128</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">11388810</pub-id></citation></ref><ref id="pone.0005156-Sijwali4"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sijwali</surname><given-names>PS</given-names></name><name><surname>Shenai</surname><given-names>BR</given-names></name><name><surname>Gut</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2001</year><article-title>Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.</article-title><source>Biochem J</source><volume>360</volume><fpage>481</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">11716777</pub-id></citation></ref><ref id="pone.0005156-Choe1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choe</surname><given-names>Y</given-names></name><name><surname>Leonetti</surname><given-names>F</given-names></name><name><surname>Greenbaum</surname><given-names>DC</given-names></name><name><surname>Lecaille</surname><given-names>F</given-names></name><name><surname>Bogyo</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>12824</fpage><lpage>12832</lpage><pub-id pub-id-type="pmid">16520377</pub-id></citation></ref><ref id="pone.0005156-Robinson1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>S</given-names></name><name><surname>Niles</surname><given-names>RK</given-names></name><name><surname>Witkowska</surname><given-names>HE</given-names></name><name><surname>Rittenbach</surname><given-names>KJ</given-names></name><name><surname>Nichols</surname><given-names>RJ</given-names></name><etal/></person-group><year>2008</year><article-title>A mass spectrometry-based strategy for detecting and characterizing endogenous proteinase activities in complex biological samples.</article-title><source>Proteomics</source><volume>8</volume><fpage>435</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">18186022</pub-id></citation></ref><ref id="pone.0005156-Miyagi1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyagi</surname><given-names>M</given-names></name><name><surname>Rao</surname><given-names>KC</given-names></name></person-group><year>2007</year><article-title>Proteolytic 18O-labeling strategies for quantitative proteomics.</article-title><source>Mass Spectrom Rev</source><volume>26</volume><fpage>121</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">17086517</pub-id></citation></ref><ref id="pone.0005156-Barrett1"><label>21</label><citation citation-type="book"><person-group person-group-type="editor"><name><surname>Barrett</surname><given-names>AJ</given-names></name><name><surname>Woessner</surname><given-names>Jf</given-names></name><name><surname>Rawlings</surname><given-names>ND</given-names></name></person-group><year>2004</year><source>Handbook of Proteolytic Enzymes</source><publisher-loc>London</publisher-loc><publisher-name>Academic Press</publisher-name></citation></ref><ref id="pone.0005156-Rosenthal3"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>PJ</given-names></name><name><surname>McKerrow</surname><given-names>JH</given-names></name><name><surname>Aikawa</surname><given-names>M</given-names></name><name><surname>Nagasawa</surname><given-names>H</given-names></name><name><surname>Leech</surname><given-names>JH</given-names></name></person-group><year>1988</year><article-title>A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum.</article-title><source>J Clin Invest</source><volume>82</volume><fpage>1560</fpage><lpage>1566</lpage><pub-id pub-id-type="pmid">3053784</pub-id></citation></ref><ref id="pone.0005156-Rosenthal4"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>PJ</given-names></name><name><surname>Wollish</surname><given-names>WS</given-names></name><name><surname>Palmer</surname><given-names>JT</given-names></name><name><surname>Rasnick</surname><given-names>D</given-names></name></person-group><year>1991</year><article-title>Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.</article-title><source>J Clin Invest</source><volume>88</volume><fpage>1467</fpage><lpage>1472</lpage><pub-id pub-id-type="pmid">1939639</pub-id></citation></ref><ref id="pone.0005156-Sijwali5"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sijwali</surname><given-names>PS</given-names></name><name><surname>Shenai</surname><given-names>BR</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2002</year><article-title>Folding of the Plasmodium falciparum cysteine protease falcipain-2 is mediated by a chaperone-like peptide and not the prodomain.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>14910</fpage><lpage>14915</lpage><pub-id pub-id-type="pmid">11827964</pub-id></citation></ref><ref id="pone.0005156-Pandey1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>KC</given-names></name><name><surname>Sijwali</surname><given-names>PS</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Na</surname><given-names>BK</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2004</year><article-title>Independent intramolecular mediators of folding, activity, and inhibition for the Plasmodium falciparum cysteine protease falcipain-2.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>3484</fpage><lpage>3491</lpage><pub-id pub-id-type="pmid">14625277</pub-id></citation></ref><ref id="pone.0005156-Pandey2"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>KC</given-names></name><name><surname>Wang</surname><given-names>SX</given-names></name><name><surname>Sijwali</surname><given-names>PS</given-names></name><name><surname>Lau</surname><given-names>AL</given-names></name><name><surname>McKerrow</surname><given-names>JH</given-names></name><etal/></person-group><year>2005</year><article-title>The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><fpage>9138</fpage><lpage>9143</lpage><pub-id pub-id-type="pmid">15964982</pub-id></citation></ref><ref id="pone.0005156-Hogg1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hogg</surname><given-names>T</given-names></name><name><surname>Nagarajan</surname><given-names>K</given-names></name><name><surname>Herzberg</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><etal/></person-group><year>2006</year><article-title>Structural and functional characterization of Falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>25425</fpage><lpage>25437</lpage><pub-id pub-id-type="pmid">16777845</pub-id></citation></ref><ref id="pone.0005156-Kerr1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>ID</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Pandey</surname><given-names>KC</given-names></name><name><surname>Harrison</surname><given-names>A</given-names></name><name><surname>Sajid</surname><given-names>M</given-names></name><etal/></person-group><year>2009</year><article-title>Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity.</article-title><source>J Med Chem</source><volume>52</volume><fpage>852</fpage><lpage>857</lpage><pub-id pub-id-type="pmid">19128015</pub-id></citation></ref><ref id="pone.0005156-Wang1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SX</given-names></name><name><surname>Pandey</surname><given-names>KC</given-names></name><name><surname>Somoza</surname><given-names>JR</given-names></name><name><surname>Sijwali</surname><given-names>PS</given-names></name><name><surname>Kortemme</surname><given-names>T</given-names></name><etal/></person-group><year>2006</year><article-title>Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease.</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>11503</fpage><lpage>11508</lpage><pub-id pub-id-type="pmid">16864794</pub-id></citation></ref><ref id="pone.0005156-Subramanian1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>S</given-names></name><name><surname>Sijwali</surname><given-names>PS</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><year>2007</year><article-title>Falcipain cysteine proteases require bipartite motifs for trafficking to the Plasmodium falciparum food vacuole.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>24961</fpage><lpage>24969</lpage><pub-id pub-id-type="pmid">17565983</pub-id></citation></ref><ref id="pone.0005156-Dasaradhi1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dasaradhi</surname><given-names>PV</given-names></name><name><surname>Korde</surname><given-names>R</given-names></name><name><surname>Thompson</surname><given-names>JK</given-names></name><name><surname>Tanwar</surname><given-names>C</given-names></name><name><surname>Nag</surname><given-names>TC</given-names></name><etal/></person-group><year>2007</year><article-title>Food vacuole targeting and trafficking of falcipain-2, an important cysteine protease of human malaria parasite Plasmodium falciparum.</article-title><source>Mol Biochem Parasitol</source><volume>156</volume><fpage>12</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">17698213</pub-id></citation></ref><ref id="pone.0005156-Thornberry1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thornberry</surname><given-names>NA</given-names></name><name><surname>Rano</surname><given-names>TA</given-names></name><name><surname>Peterson</surname><given-names>EP</given-names></name><name><surname>Rasper</surname><given-names>DM</given-names></name><name><surname>Timkey</surname><given-names>T</given-names></name><etal/></person-group><year>1997</year><article-title>A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis.</article-title><source>J Biol Chem</source><volume>272</volume><fpage>17907</fpage><lpage>17911</lpage><pub-id pub-id-type="pmid">9218414</pub-id></citation></ref><ref id="pone.0005156-Ruggles1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruggles</surname><given-names>SW</given-names></name><name><surname>Fletterick</surname><given-names>RJ</given-names></name><name><surname>Craik</surname><given-names>CS</given-names></name></person-group><year>2004</year><article-title>Characterization of structural determinants of granzyme B reveals potent mediators of extended substrate specificity.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>30751</fpage><lpage>30759</lpage><pub-id pub-id-type="pmid">15123647</pub-id></citation></ref><ref id="pone.0005156-Harris1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>JL</given-names></name><name><surname>Peterson</surname><given-names>EP</given-names></name><name><surname>Hudig</surname><given-names>D</given-names></name><name><surname>Thornberry</surname><given-names>NA</given-names></name><name><surname>Craik</surname><given-names>CS</given-names></name></person-group><year>1998</year><article-title>Definition and redesign of the extended substrate specificity of granzyme B.</article-title><source>J Biol Chem</source><volume>273</volume><fpage>27364</fpage><lpage>27373</lpage><pub-id pub-id-type="pmid">9765264</pub-id></citation></ref><ref id="pone.0005156-Goetz1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goetz</surname><given-names>DH</given-names></name><name><surname>Choe</surname><given-names>Y</given-names></name><name><surname>Hansell</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>YT</given-names></name><name><surname>McDowell</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus.</article-title><source>Biochemistry</source><volume>46</volume><fpage>8744</fpage><lpage>8752</lpage><pub-id pub-id-type="pmid">17605471</pub-id></citation></ref><ref id="pone.0005156-Sojka1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sojka</surname><given-names>D</given-names></name><name><surname>Hajdusek</surname><given-names>O</given-names></name><name><surname>Dvorak</surname><given-names>J</given-names></name><name><surname>Sajid</surname><given-names>M</given-names></name><name><surname>Franta</surname><given-names>Z</given-names></name><etal/></person-group><year>2007</year><article-title>IrAE: an asparaginyl endopeptidase (legumain) in the gut of the hard tick Ixodes ricinus.</article-title><source>Int J Parasitol</source><volume>37</volume><fpage>713</fpage><lpage>724</lpage><pub-id pub-id-type="pmid">17336985</pub-id></citation></ref><ref id="pone.0005156-Debela1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Debela</surname><given-names>M</given-names></name><name><surname>Magdolen</surname><given-names>V</given-names></name><name><surname>Schechter</surname><given-names>N</given-names></name><name><surname>Valachova</surname><given-names>M</given-names></name><name><surname>Lottspeich</surname><given-names>F</given-names></name><etal/></person-group><year>2006</year><article-title>Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>25678</fpage><lpage>25688</lpage><pub-id pub-id-type="pmid">16740631</pub-id></citation></ref><ref id="pone.0005156-Rosenthal5"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>PJ</given-names></name><name><surname>Olson</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>GK</given-names></name><name><surname>Palmer</surname><given-names>JT</given-names></name><name><surname>Klaus</surname><given-names>JL</given-names></name><etal/></person-group><year>1996</year><article-title>Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors.</article-title><source>Antimicrob Agents Chemother</source><volume>40</volume><fpage>1600</fpage><lpage>1603</lpage><pub-id pub-id-type="pmid">8807047</pub-id></citation></ref><ref id="pone.0005156-Lee1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>BJ</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Chiang</surname><given-names>P</given-names></name><name><surname>Kemp</surname><given-names>SJ</given-names></name><name><surname>Goldman</surname><given-names>EA</given-names></name><etal/></person-group><year>2003</year><article-title>Antimalarial activities of novel synthetic cysteine protease inhibitors.</article-title><source>Antimicrob Agents Chemother</source><volume>47</volume><fpage>3810</fpage><lpage>3814</lpage><pub-id pub-id-type="pmid">14638488</pub-id></citation></ref><ref id="pone.0005156-Kuhn1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>Y</given-names></name><name><surname>Rohrbach</surname><given-names>P</given-names></name><name><surname>Lanzer</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin.</article-title><source>Cell Microbiol</source><volume>9</volume><fpage>1004</fpage><lpage>1013</lpage><pub-id pub-id-type="pmid">17381432</pub-id></citation></ref><ref id="pone.0005156-Bennett1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>TN</given-names></name><name><surname>Kosar</surname><given-names>AD</given-names></name><name><surname>Ursos</surname><given-names>LM</given-names></name><name><surname>Dzekunov</surname><given-names>S</given-names></name><name><surname>Singh Sidhu</surname><given-names>AB</given-names></name><etal/></person-group><year>2004</year><article-title>Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH.</article-title><source>Mol Biochem Parasitol</source><volume>133</volume><fpage>99</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">14668017</pub-id></citation></ref><ref id="pone.0005156-Krogstad1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krogstad</surname><given-names>DJ</given-names></name><name><surname>Schlesinger</surname><given-names>PH</given-names></name><name><surname>Gluzman</surname><given-names>IY</given-names></name></person-group><year>1985</year><article-title>Antimalarials increase vesicle pH in Plasmodium falciparum.</article-title><source>J Cell Biol</source><volume>101</volume><fpage>2302</fpage><lpage>2309</lpage><pub-id pub-id-type="pmid">3905824</pub-id></citation></ref><ref id="pone.0005156-Yayon1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yayon</surname><given-names>A</given-names></name><name><surname>Cabantchik</surname><given-names>ZI</given-names></name><name><surname>Ginsburg</surname><given-names>H</given-names></name></person-group><year>1984</year><article-title>Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine.</article-title><source>Embo J</source><volume>3</volume><fpage>2695</fpage><lpage>2700</lpage><pub-id pub-id-type="pmid">6391917</pub-id></citation></ref><ref id="pone.0005156-Brindley1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brindley</surname><given-names>PJ</given-names></name><name><surname>Kalinna</surname><given-names>BH</given-names></name><name><surname>Wong</surname><given-names>JY</given-names></name><name><surname>Bogitsh</surname><given-names>BJ</given-names></name><name><surname>King</surname><given-names>LT</given-names></name><etal/></person-group><year>2001</year><article-title>Proteolysis of human hemoglobin by schistosome cathepsin D.</article-title><source>Mol Biochem Parasitol</source><volume>112</volume><fpage>103</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">11166391</pub-id></citation></ref><ref id="pone.0005156-Banerjee1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Beatty</surname><given-names>W</given-names></name><name><surname>Pelosof</surname><given-names>L</given-names></name><name><surname>Klemba</surname><given-names>M</given-names></name><etal/></person-group><year>2002</year><article-title>Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine.</article-title><source>Proc Natl Acad Sci U S A</source><volume>99</volume><fpage>990</fpage><lpage>995</lpage><pub-id pub-id-type="pmid">11782538</pub-id></citation></ref><ref id="pone.0005156-Klemba1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klemba</surname><given-names>M</given-names></name><name><surname>Gluzman</surname><given-names>I</given-names></name><name><surname>Goldberg</surname><given-names>DE</given-names></name></person-group><year>2004</year><article-title>A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>43000</fpage><lpage>43007</lpage><pub-id pub-id-type="pmid">15304495</pub-id></citation></ref><ref id="pone.0005156-Dalal1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dalal</surname><given-names>S</given-names></name><name><surname>Klemba</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>35978</fpage><lpage>35987</lpage><pub-id pub-id-type="pmid">17895246</pub-id></citation></ref><ref id="pone.0005156-Eggleson1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eggleson</surname><given-names>KK</given-names></name><name><surname>Duffin</surname><given-names>KL</given-names></name><name><surname>Goldberg</surname><given-names>DE</given-names></name></person-group><year>1999</year><article-title>Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum.</article-title><source>J Biol Chem</source><volume>274</volume><fpage>32411</fpage><lpage>32417</lpage><pub-id pub-id-type="pmid">10542284</pub-id></citation></ref><ref id="pone.0005156-Murata1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murata</surname><given-names>CE</given-names></name><name><surname>Goldberg</surname><given-names>DE</given-names></name></person-group><year>2003</year><article-title>Plasmodium falciparum falcilysin: a metalloprotease with dual specificity.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>38022</fpage><lpage>38028</lpage><pub-id pub-id-type="pmid">12876284</pub-id></citation></ref><ref id="pone.0005156-Bonilla1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonilla</surname><given-names>JA</given-names></name><name><surname>Bonilla</surname><given-names>TD</given-names></name><name><surname>Yowell</surname><given-names>CA</given-names></name><name><surname>Fujioka</surname><given-names>H</given-names></name><name><surname>Dame</surname><given-names>JB</given-names></name></person-group><year>2007</year><article-title>Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function.</article-title><source>Mol Microbiol</source><volume>65</volume><fpage>64</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">17581121</pub-id></citation></ref><ref id="pone.0005156-Bonilla2"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonilla</surname><given-names>JA</given-names></name><name><surname>Moura</surname><given-names>PA</given-names></name><name><surname>Bonilla</surname><given-names>TD</given-names></name><name><surname>Yowell</surname><given-names>CA</given-names></name><name><surname>Fidock</surname><given-names>DA</given-names></name><etal/></person-group><year>2007</year><article-title>Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum.</article-title><source>Int J Parasitol</source><volume>37</volume><fpage>317</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">17207486</pub-id></citation></ref><ref id="pone.0005156-Drew1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drew</surname><given-names>ME</given-names></name><name><surname>Banerjee</surname><given-names>R</given-names></name><name><surname>Uffman</surname><given-names>EW</given-names></name><name><surname>Gilbertson</surname><given-names>S</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name><etal/></person-group><year>2008</year><article-title>Plasmodium food vacuole plasmepsins are activated by falcipains.</article-title><source>J Biol Chem</source><volume>283</volume><fpage>12870</fpage><lpage>12876</lpage><pub-id pub-id-type="pmid">18308731</pub-id></citation></ref><ref id="pone.0005156-Hanspal1"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanspal</surname><given-names>M</given-names></name><name><surname>Dua</surname><given-names>M</given-names></name><name><surname>Takakuwa</surname><given-names>Y</given-names></name><name><surname>Chishti</surname><given-names>AH</given-names></name><name><surname>Mizuno</surname><given-names>A</given-names></name></person-group><year>2002</year><article-title>Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development.</article-title><source>Blood</source><volume>100</volume><fpage>1048</fpage><lpage>1054</lpage><pub-id pub-id-type="pmid">12130521</pub-id></citation></ref><ref id="pone.0005156-Dhawan1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dhawan</surname><given-names>S</given-names></name><name><surname>Dua</surname><given-names>M</given-names></name><name><surname>Chishti</surname><given-names>AH</given-names></name><name><surname>Hanspal</surname><given-names>M</given-names></name></person-group><year>2003</year><article-title>Ankyrin peptide blocks falcipain-2-mediated malaria parasite release from red blood cells.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>30180</fpage><lpage>30186</lpage><pub-id pub-id-type="pmid">12775709</pub-id></citation></ref><ref id="pone.0005156-Dasaradhi2"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dasaradhi</surname><given-names>PV</given-names></name><name><surname>Mohmmed</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Hossain</surname><given-names>MJ</given-names></name><name><surname>Bhatnagar</surname><given-names>RK</given-names></name><etal/></person-group><year>2005</year><article-title>A role of falcipain-2, principal cysteine proteases of Plasmodium falciparum in merozoite egression.</article-title><source>Biochem Biophys Res Commun</source><volume>336</volume><fpage>1062</fpage><lpage>1068</lpage><pub-id pub-id-type="pmid">16165088</pub-id></citation></ref><ref id="pone.0005156-Kolakovich1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kolakovich</surname><given-names>KA</given-names></name><name><surname>Gluzman</surname><given-names>IY</given-names></name><name><surname>Duffin</surname><given-names>KL</given-names></name><name><surname>Goldberg</surname><given-names>DE</given-names></name></person-group><year>1997</year><article-title>Generation of hemoglobin peptides in the acidic digestive vacuole of Plasmodium falciparum implicates peptide transport in amino acid production.</article-title><source>Mol Biochem Parasitol</source><volume>87</volume><fpage>123</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">9247924</pub-id></citation></ref><ref id="pone.0005156-Modiano1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Modiano</surname><given-names>D</given-names></name><name><surname>Luoni</surname><given-names>G</given-names></name><name><surname>Sirima</surname><given-names>BS</given-names></name><name><surname>Simpore</surname><given-names>J</given-names></name><name><surname>Verra</surname><given-names>F</given-names></name><etal/></person-group><year>2001</year><article-title>Haemoglobin C protects against clinical Plasmodium falciparum malaria.</article-title><source>Nature</source><volume>414</volume><fpage>305</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">11713529</pub-id></citation></ref><ref id="pone.0005156-Fairhurst1"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fairhurst</surname><given-names>RM</given-names></name><name><surname>Fujioka</surname><given-names>H</given-names></name><name><surname>Hayton</surname><given-names>K</given-names></name><name><surname>Collins</surname><given-names>KF</given-names></name><name><surname>Wellems</surname><given-names>TE</given-names></name></person-group><year>2003</year><article-title>Aberrant development of Plasmodium falciparum in hemoglobin CC red cells: implications for the malaria protective effect of the homozygous state.</article-title><source>Blood</source><volume>101</volume><fpage>3309</fpage><lpage>3315</lpage><pub-id pub-id-type="pmid">12480691</pub-id></citation></ref><ref id="pone.0005156-May1"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>JA</given-names></name><name><surname>Timmann</surname><given-names>C</given-names></name><name><surname>Ehmen</surname><given-names>C</given-names></name><name><surname>Busch</surname><given-names>W</given-names></name><etal/></person-group><year>2007</year><article-title>Hemoglobin variants and disease manifestations in severe falciparum malaria.</article-title><source>Jama</source><volume>297</volume><fpage>2220</fpage><lpage>2226</lpage><pub-id pub-id-type="pmid">17519411</pub-id></citation></ref><ref id="pone.0005156-Williams1"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>TN</given-names></name><name><surname>Mwangi</surname><given-names>TW</given-names></name><name><surname>Wambua</surname><given-names>S</given-names></name><name><surname>Alexander</surname><given-names>ND</given-names></name><name><surname>Kortok</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases.</article-title><source>J Infect Dis</source><volume>192</volume><fpage>178</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">15942909</pub-id></citation></ref><ref id="pone.0005156-Aidoo1"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aidoo</surname><given-names>M</given-names></name><name><surname>Terlouw</surname><given-names>DJ</given-names></name><name><surname>Kolczak</surname><given-names>MS</given-names></name><name><surname>McElroy</surname><given-names>PD</given-names></name><name><surname>ter Kuile</surname><given-names>FO</given-names></name><etal/></person-group><year>2002</year><article-title>Protective effects of the sickle cell gene against malaria morbidity and mortality.</article-title><source>Lancet</source><volume>359</volume><fpage>1311</fpage><lpage>1312</lpage><pub-id pub-id-type="pmid">11965279</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported by the National Institutes of Health (AI AI035800 and AI35707 for PJR and AI35707 for CSC). PJR is a Doris Duke Charitable Foundation Distinguished Clinical Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 